http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535805-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D25-2811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D83-0409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D83-0847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0061
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2008-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010535805-A
titleOfInvention Compositions and methods for sedation and analgesia during treatment using oral transmucosal dosage forms
abstract Provided are dosage forms for sedation and analgesia during treatment, including combinations of opioids such as sufentanil and benzodiazepines such as triazolam, for administration via the oral transmucosal route, and methods of using the same. The In one embodiment, the dosage form of the present invention has a mass of less than 100 mg and comprises from about 5 mcg to about 50 mcg sufentanil and from about 100 mcg to about 500 mcg triazolam. Furthermore, oral transmucosal administration of this solid dosage form to subjects results in a sufentanil T max with an overall mean coefficient of variation of less than 40%.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016504405-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017146104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017146104-A1
priorityDate 2007-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006097361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004520410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007081949-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20849238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453834176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449812066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407174045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412303135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9911821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533788
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10070040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493117

Total number of triples: 82.